Pacira Reaches IP Deal Allowing Generic Painkiller In 2030
By Adam Lidgett · April 8, 2025, 6:21 PM EDT
Pacira BioSciences has agreed to settle a series of patent infringement lawsuits against Fresenius Kabi and other pharmaceutical companies over Pacira's drug Exparel, a long-acting injectable for managing postsurgical pain....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login